These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38964518)

  • 1. Synthesis and biological evaluation of novel penindolone derivatives as potential antiproliferative agents against SCLC in vitro.
    Lin J; Han Y; Li B; Gai W; Wang Z; Wang Q; Teng Y; Li J; Li D
    Bioorg Med Chem Lett; 2024 Sep; 110():129877. PubMed ID: 38964518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel indole hydrazide derivatives: Synthesis and their antiproliferative activities through inducing apoptosis and DNA damage.
    Kilic-Kurt Z; Acar C; Ergul M; Bakar-Ates F; Altuntas TG
    Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000059. PubMed ID: 32419228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.
    Preti D; Romagnoli R; Rondanin R; Cacciari B; Hamel E; Balzarini J; Liekens S; Schols D; Estévez-Sarmiento F; Quintana J; Estévez F
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1225-1238. PubMed ID: 30141353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentapeptides for the treatment of small cell lung cancer: Optimisation by N
    Haitham Abusara O; Freeman S; Aojula HS
    Eur J Med Chem; 2017 Sep; 137():221-232. PubMed ID: 28595067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of novel 2,3-indolinedione derivatives against mantle cell lymphoma.
    Yu S; Liu Y; Zhang Z; Zhang J; Zhao G
    Bioorg Med Chem; 2019 Aug; 27(15):3319-3327. PubMed ID: 31229421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of new indole containing biaryl derivatives as potent antiproliferative agents.
    Yuan S; Feng SQ; Li AQ; Zuo JH; Zhang DQ; Xing YJ; Xie Z; Yu B; Liu HM
    Bioorg Chem; 2021 May; 110():104821. PubMed ID: 33812156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, biological evaluation and structure-activity relationship of sophoridine derivatives bearing pyrrole or indole scaffold as potential antitumor agents.
    Li Z; Luo M; Cai B; Haroon-Ur-Rashid ; Huang M; Jiang J; Wang L; Wu L
    Eur J Med Chem; 2018 Sep; 157():665-682. PubMed ID: 30125725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a series of novel 4-anlinoquinazoline derivatives possessing quinazoline skeleton: Design, synthesis, EGFR kinase inhibitory efficacy, and evaluation of anticancer activities in vitro.
    Chang J; Ren H; Zhao M; Chong Y; Zhao W; He Y; Zhao Y; Zhang H; Qi C
    Eur J Med Chem; 2017 Sep; 138():669-688. PubMed ID: 28711702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel indolizino[8,7-b]indole hybrids as anti-small cell lung cancer agents: Regioselective modulation of topoisomerase II inhibitory and DNA crosslinking activities.
    Chang SM; Christian W; Wu MH; Chen TL; Lin YW; Suen CS; Pidugu HB; Detroja D; Shah A; Hwang MJ; Su TL; Lee TC
    Eur J Med Chem; 2017 Feb; 127():235-249. PubMed ID: 28064078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as antiproliferative EGFR and BRAF
    Al-Wahaibi LH; Gouda AM; Abou-Ghadir OF; Salem OIA; Ali AT; Farghaly HS; Abdelrahman MH; Trembleau L; Abdu-Allah HHM; Youssif BGM
    Bioorg Chem; 2020 Nov; 104():104260. PubMed ID: 32920363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and biological evaluation of novel thiosemicarbazone-indole derivatives targeting prostate cancer cells.
    He ZX; Huo JL; Gong YP; An Q; Zhang X; Qiao H; Yang FF; Zhang XH; Jiao LM; Liu HM; Ma LY; Zhao W
    Eur J Med Chem; 2021 Jan; 210():112970. PubMed ID: 33153765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of 2-indolinone derivatives as potential antitumor agents.
    Zou H; Zhang L; Ouyang J; Giulianotti MA; Yu Y
    Eur J Med Chem; 2011 Dec; 46(12):5970-7. PubMed ID: 22019188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and in vitro antitumor evaluation of novel pyrazole-benzimidazole derivatives.
    Ren B; Liu RC; Ji K; Tang JJ; Gao JM
    Bioorg Med Chem Lett; 2021 Jul; 43():128097. PubMed ID: 33979690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Anticancer Activity of Novel Indole Derivatives as Dual EGFR/SRC Kinase Inhibitors.
    Olgen S; Kaleli SNB; Karaca BT; Demirel UU; Bristow HK
    Curr Med Chem; 2024; 31(24):3798-3817. PubMed ID: 37365789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of novel 7-azaindazolyl-indolyl-maleimide derivatives as antitumor agents and protein kinase C inhibitors.
    Ye Q; Cao J; Zhou X; Lv D; He Q; Yang B; Hu Y
    Bioorg Med Chem; 2009 Jul; 17(13):4763-72. PubMed ID: 19447039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of spiro[cyclopropane-1,3'-indolin]-2'-ones as potential anticancer agents.
    Reddy CN; Nayak VL; Mani GS; Kapure JS; Adiyala PR; Maurya RA; Kamal A
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4580-6. PubMed ID: 26330077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis and anti-leukaemia activity of novel indole derivatives as potent colchicine binding site inhibitors.
    Yao Y; Huang T; Wang Y; Wang L; Feng S; Cheng W; Yang L; Duan Y
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):652-665. PubMed ID: 35109719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of novel 4-anlinoquinazoline derivatives as EGFR inhibitors with the potential to inhibit the gefitinib-resistant nonsmall cell lung cancers.
    Wang C; Xu S; Peng L; Zhang B; Zhang H; Hu Y; Zheng P; Zhu W
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):203-217. PubMed ID: 30835140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of novel ligustrazine-chalcone derivatives as potential anti-triple negative breast cancer agents.
    Luo Y; Wu W; Zha D; Zhou W; Wang C; Huang J; Chen S; Yu L; Li Y; Huang Q; Zhang J; Zhang C
    Bioorg Med Chem Lett; 2021 Sep; 47():128230. PubMed ID: 34186178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of indole-2-one derivatives as BRD4 (BD1) selective inhibitors.
    Qiao XP; Wang XT; Wang S; Mu HX; Wang QS; Chen SW
    Bioorg Med Chem; 2024 May; 106():117752. PubMed ID: 38749341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.